ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CAH vs MCK // FORWARD P/E MULTIPLE

Cardinal Health Inc. (NYSE) VS. McKesson Corporation (NYSE) • 15-METRIC TALLY: CAH 3 — MCK 11
▲ FORWARD P/E MULTIPLE LEADER: MCK
forward-pe
20.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CAH VS. MCK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CAH MCK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 3.70% 3.60% +0.10 CAH /gross-margins <GO>
Return on Invested Capital (ROIC) 29.70% 38.60% -8.90 MCK /roic <GO>
EV/EBITDA & P/E Valuation 24.5x 19.5x +5.00 MCK /valuation <GO>
Free Cash Flow Yield 3.18% 5.00% -1.82 MCK /fcf-yield <GO>
Operating Margin 1.00% 1.50% -0.50 MCK /operating-margins <GO>
Net Profit Margin 0.70% 1.20% -0.50 MCK /net-margins <GO>
Revenue Growth (YoY) -1.90% 12.40% -14.30 MCK /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.85% 0.33% +0.52 CAH /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.16 6.96 -1.80 MCK /balance-sheet <GO>
Piotroski F-Score Quality 6/9 7/9 -1.00 MCK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.1 56.1 +3.00 CAH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 0.95 -0.05 MCK /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE 34.6x 20.2x +14.40 MCK /forward-pe <GO>
Enterprise Scale & Market Cap $58.14B $114.36B -$56.22B MCK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CAH REV MCK REV CAH GROSS % MCK GROSS % CAH FCF MCK FCF
FY 2025 $222.58B $403.43B 3.7% 3.6% $1.85B $5.72B
FY 2024 $226.83B $359.05B 3.3% 3.7% $3.25B $5.55B
FY 2023 $204.98B $308.95B — — -$6.38B -$9.59B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CAH // BETA 0.90
MCK // BETA 0.95